Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.435 +0.035 (+2.50%)
Streaming Delayed Price Updated: 1:14 PM EDT, Apr 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Neuronetics (STIM) Q4 2025 Earnings Transcript ↗
Neuronetics (STIM) Q4 2025 Earnings Transcript 
Via The Motley Fool
NEURONETICS INC (NASDAQ:STIM) Reports Q4 Revenue Beat but Shares Drop on Cautious Outlook ↗
Via Chartmill
Which stocks are experiencing notable movement on Wednesday? ↗
Via Chartmill
Top stock movements in today's session. ↗
Via Chartmill
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For November 12, 2024 ↗
 
Via Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
Via Chartmill
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Via Chartmill
Wondering what's happening in today's after-hours session? ↗
Via Chartmill
News headline image
Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗
 
Via Benzinga
News headline image
Tuesday's pre-market session: top gainers and losers ↗
The US market session of Tuesday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
News headline image
NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss ↗
Neuronetics (STIM) Q3 2025 results: revenue miss sparks a 22% stock drop despite a narrower-than-expected EPS loss. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss ↗
Neuronetics (STIM) reported mixed Q2 2025 results, beating revenue estimates but posting a wider-than-expected loss, causing a 9% pre-market drop. Greenbrook clinics hit record revenue. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 4, 2025 ↗
 
Via Benzinga
News headline image
What's going on in today's pre-market session ↗
Discover the top movers in Friday's pre-market session and stay informed about market dynamics. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
These stocks are moving in today's after hours session ↗
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Retractable Technologies And 2 Other Penny Stocks Executives Are Buying ↗
 
Via Benzinga
News headline image
Butterfly Network And 3 Other Stocks Under $2 Executives Are Aggressively Buying ↗
 
Via Benzinga
News headline image
Gold Gains Over 1%; Starbucks Shares Move Higher ↗
 
Via Benzinga
News headline image
Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations ↗
Neuronetics to acquire Greenbrook TMS (OTC: GBNHF) in an all-stock deal, doubling revenue to $145M. The combined company expects mid-teens growth in 2025 and 2026, with $15M in cost savings and... 
Via Benzinga
News headline image
Crude Oil Surges 2%; B. Riley Financial Shares Plunge ↗
 
Via Benzinga
News headline image
STIM Stock Earnings: Neuronetics Misses EPS, Misses Revenue for Q2 2024 ↗
STIM stock results show that Neuronetics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Dow Dips 150 Points; Monday.com Posts Upbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
3 Neurotech Stocks Bridging Mind and Machine ↗
These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners. 
Via InvestorPlace
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.